<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-07-27">27 July 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Denise</forename><surname>Hilfiker-Kleiner</surname></persName>
							<email>hilfiker.denise@mh-hannover.de</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Cardiology and Angiology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<addrLine>Carl-Neuberg-Str. 1</addrLine>
									<postCode>D-30625</postCode>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Arash</forename><surname>Haghikia</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Cardiology and Angiology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<addrLine>Carl-Neuberg-Str. 1</addrLine>
									<postCode>D-30625</postCode>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charite ´-Universit€ atsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin, Hindenburgdamm 30</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dominik</forename><surname>Berliner</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Cardiology and Angiology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<addrLine>Carl-Neuberg-Str. 1</addrLine>
									<postCode>D-30625</postCode>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jens</forename><surname>Vogel-Claussen</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Institute for Diagnostic and Interventional Radiology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<addrLine>Carl-Neuberg-Str. 1</addrLine>
									<postCode>30625</postCode>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johannes</forename><surname>Schwab</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Innere Medizin 8 -Schwerpunkt Kardiologie und Institut fu ¨r Radiologie und Neuroradiologie</orgName>
								<orgName type="institution">Universit€ atsklinik fu ¨r</orgName>
								<address>
									<settlement>Klinikum Nu</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Annegret</forename><surname>Franke</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution" key="instit1">University Leipzig</orgName>
								<orgName type="institution" key="instit2">Clinical Trial Centre (KKS)</orgName>
								<orgName type="institution" key="instit3">ZKS Leipzig</orgName>
								<address>
									<addrLine>Haertelstr. 16-18</addrLine>
									<postCode>D-04103</postCode>
									<settlement>Leipzig</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marziel</forename><surname>Schwarzkopf</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution" key="instit1">University Leipzig</orgName>
								<orgName type="institution" key="instit2">Clinical Trial Centre (KKS)</orgName>
								<orgName type="institution" key="instit3">ZKS Leipzig</orgName>
								<address>
									<addrLine>Haertelstr. 16-18</addrLine>
									<postCode>D-04103</postCode>
									<settlement>Leipzig</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Philipp</forename><surname>Ehlermann</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Department of Cardiology, Angiology, and Pneumology</orgName>
								<orgName type="institution">University of Heidelberg</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 410</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Roman</forename><surname>Pfister</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Cardiology, Pulmonology, and Vascular Medicine</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<addrLine>Kerpenerstr. 62, 50937 Ko ¨ln</addrLine>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Guido</forename><surname>Michels</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Cardiology, Pulmonology, and Vascular Medicine</orgName>
								<orgName type="institution">University of Cologne</orgName>
								<address>
									<addrLine>Kerpenerstr. 62, 50937 Ko ¨ln</addrLine>
									<settlement>Cologne</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ralf</forename><surname>Westenfeld</surname></persName>
							<affiliation key="aff7">
								<orgName type="department" key="dep1">Department of Cardiology, Pulmonology, and Vascular Medicine</orgName>
								<orgName type="department" key="dep2">Medical Faculty</orgName>
								<orgName type="institution">University Duesseldorf</orgName>
								<address>
									<settlement>Duesseldorf</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Verena</forename><surname>Stangl</surname></persName>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Department for Cardiology and Angiology</orgName>
								<orgName type="department" key="dep2">Center for Cardiovascular Research (CCR)</orgName>
								<orgName type="department" key="dep3">10 Department of Internal Medicine III</orgName>
								<orgName type="department" key="dep4">11 Department of Internal Medicine I</orgName>
								<orgName type="institution">University Hospital of the Saarland</orgName>
								<address>
									<addrLine>Charite ´platz 1</addrLine>
									<postCode>10117, 66421</postCode>
									<settlement>Angiologie, Charite ´-Universit€ atsmedizin Berlin, Berlin, Homburg, Saar</settlement>
									<country>Germany;, Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="institution">University Hospital Wuerzburg</orgName>
								<address>
									<addrLine>Am Schwarzenberg 15, Haus A1597078 Wu ¨rzburg</addrLine>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ingrid</forename><surname>Kindermann</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Uwe</forename><surname>Ku ¨hl</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charite ´-Universit€ atsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin, Hindenburgdamm 30</addrLine>
									<postCode>12203</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christiane</forename><forename type="middle">E</forename><surname>Angermann</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Axel</forename><surname>Schlitt</surname></persName>
							<affiliation key="aff10">
								<orgName type="department">Department of Medicine III</orgName>
								<orgName type="institution" key="instit1">Medizinische Fakult€ at der Martin Luther</orgName>
								<orgName type="institution" key="instit2">Universit€ at Halle-Wittenberg</orgName>
								<address>
									<addrLine>Magdeburger Strabe 8</addrLine>
									<postCode>06108</postCode>
									<settlement>Halle</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dieter</forename><surname>Fischer</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Cardiology and Angiology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<addrLine>Carl-Neuberg-Str. 1</addrLine>
									<postCode>D-30625</postCode>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Edith</forename><surname>Podewski</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Cardiology and Angiology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<addrLine>Carl-Neuberg-Str. 1</addrLine>
									<postCode>D-30625</postCode>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><forename type="middle">Bo</forename><surname>¨hm</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Karen</forename><surname>Sliwa</surname></persName>
							<affiliation key="aff11">
								<orgName type="department">Faculty of Health Sciences</orgName>
								<orgName type="institution">Hatter Institute of Cardiology Research in Africa</orgName>
								<address>
									<addrLine>2 Anzio Road, Chris Barnard Building, 4th Floor</addrLine>
									<postCode>OBSERVATORY 7925</postCode>
									<country key="ZA">South Africa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Johann</forename><surname>Bauersachs</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Cardiology and Angiology</orgName>
								<orgName type="department" key="dep2">Hannover Medical School</orgName>
								<address>
									<addrLine>Carl-Neuberg-Str. 1</addrLine>
									<postCode>D-30625</postCode>
									<settlement>Hannover</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-07-27">27 July 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">C84AF467DF4275FCC0E80DB787C84D94</idno>
					<idno type="DOI">10.1093/eurheartj/ehx428</idno>
					<note type="submission">Received 10 April 2017; revised 16 May 2017; editorial decision 2 June 2017; accepted 23 June 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:49+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>ClinicalTrials.gov, study number: NCT00998556</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Aims</head><p><s>An anti-angiogenic cleaved prolactin fragment is considered causal for peripartum cardiomyopathy (PPCM).</s><s>Experimental and first clinical observations suggested beneficial effects of the prolactin release inhibitor bromocriptine in PPCM.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>6]<ref type="bibr" target="#b6">[7]</ref> To date no evidence-based disease specific therapy is available for PPCM.</s><s>2]<ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref> Hereby, high levels of the nursing hormone prolactin and the production of a cleaved 16kDa N-terminal fragment of prolactin have emerged as potential key factors in the pathophysiology of PPCM.</s><s>2]<ref type="bibr" target="#b13">[13]</ref><ref type="bibr" target="#b14">[14]</ref> Bromocriptine has been used for many years to stop lactation in postpartum women.</s><s>In addition, prolactin-independent cytoprotective effects of bromocriptine were also shown in various organs including the heart. <ref type="bibr" target="#b14">14,</ref><ref type="bibr" target="#b15">15</ref></s><s>The strong improvement of cardiac function in previous reports including a clinical pilot study and register-based data demonstrating that prolonged treatment of PPCM patients with bromocriptine is feasible and may improve left ventricular (LV) recovery and clinical outcome <ref type="bibr" target="#b12">12,</ref><ref type="bibr" target="#b16">16,</ref><ref type="bibr" target="#b17">17</ref> lend support to the hypothesis that prolonged bromocriptine treatment beyond the cumulative dose to stop lactation might be needed to achieve maximum clinical benefits.</s><s>We therefore designed this randomized multicentre trial to compare the effects of prolonged bromocriptine treatment vs. short-term treatment sufficient to stop lactation in addition to guideline-based heart failure therapy <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b10">10</ref> on LV function and clinical outcomes in patients with PPCM. <ref type="bibr" target="#b18">18</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>The study design has been reported previously. <ref type="bibr" target="#b18">18</ref></s><s>etailed information on the study protocol and methods are provided in the Supplementary material online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Screening, inclusion criteria, and randomization of study patients</head><p><s>From June 2010 until September 2015, 140 patients at 12 centres were screened for eligibility.</s><s>Of these patients, 63 were included in the study while 77 patients did not fulfil the criteria for randomization.</s><s>Reasons for exclusion were LVEF &gt; 35%, other reasons for heart failure, time since delivery more than 6 months, social reasons, not agreed to participate in the study, drug abuse, incompliance and other reasons.</s><s>All patients included in the study were postpartum.</s><s>Accordingly, 32 patients were randomly assigned to receive 2.5 mg bromocriptine for 1 week (1W group) and 31 to receive 5 mg bromocriptine for 2 weeks followed by 2.5 mg for 6 weeks (8W group).</s><s>In the 1W group, three patients withdrew consent after randomization, one was lost to follow-up, one did not undergo valid randomization.</s><s>An additional patient of the 1W group was not treated according to the protocol but received higher dose of bromocriptine (up to 10 mg) and relevantly longer so that the clinical event committee (CEC) decided to exclude her from all between-groups comparisons of efficacy end points.</s><s>Therefore, 31 patients per group comprised the efficacy analysis set of patients.</s><s>In total, 26 patients from the 1W group and 31 from the 8W group completed the study with follow-up data of 6 months after diagnosis (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>Of these patients, 23 patients from the 1W and 28 patients from the 8W group met the imaging quality standards evaluated by the CEC in order to be taken into consideration for the primary end point (trial profile is shown in Figure <ref type="figure" target="#fig_0">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Baseline characteristics of study patients</head><p><s>The characteristics of all randomized patients at baseline (Visit 1) are shown in Table <ref type="table" target="#tab_0">1</ref>.</s><s>More details about the baseline characteristics are provided in the Supplementary material online, Appendix Tables S1-S8.</s><s>The groups were balanced with respect to baseline characteristics (age, gravida, parity, race, body mass index, haemodynamics, cardiac function New York Heart Association class), cardiovascular and pregnancy-related risk factors.</s><s>Data for right ventricular ejection fraction (RVEF) as assessed by CMR were available for 44 patients.</s><s>Baseline RVEF did not differ significantly between 1W (48 ± 12%, n = 20) and 8W (42 ± 13%, n = 24; 1W vs. 8W: P = 0.20).</s><s>The prevalence of impaired RV function (RVEF &lt; 40%) did not differ significantly between both groups (20% in 1W vs. 42% in 8W, P = 0.19) although patients in the 8W group tended to have more often impaired RV function at baseline.</s><s>No patient was diagnosed with PPCM in a previous pregnancy or was diagnosed during pregnancy.</s><s>Diagnosis was made 1.6 ± 1.6 months after delivery and average time between first symptoms and diagnosis was 0.8 ± 1.2 months with no difference between groups.</s><s>All patients were randomized postpartum.</s><s>Randomization was done no more than 7 days after first diagnosis of PPCM.</s><s>One patient was of African race, all other were of Caucasian race.</s><s>Notably, use of guideline-based heart failure therapy including ACE inhibition or angiotensin receptor blocker (ARB), beta-blockade and mineralocorticoid receptor antagonist (MRA) <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b10">10</ref> during the study was high and did not differ between both groups (Table <ref type="table" target="#tab_0">1</ref> Plus-minus values are means ± SD.</s><s>There were no significant differences between the two groups.</s><s>Data were missing for the following characteristics: N-terminal pro-B-type natriuretic peptide for 1 patient in the 1W group and 1 in the 8W group, respectively, body-mass index, for 1 patient in the 1W group.</s><s>Percentages may not total 100 because of rounding.</s><s>To convert the values for creatinine to micromoles per litre, multiply by 88.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Change in left ventricular function as primary end point</head><p><s>The LVEF increased from a mean of 28 ± 10% at baseline to 49 ± 12% at 6 months in the 1W group (n = 23), and from 27 ± 10% to 51 ± 10% in the 8W group (n = 28) with a between-groups difference at 6-months follow-up of 2.0 [95% confidence limit: -4.2; 8.2]% in favour of the 8W groups.</s><s>Individual courses are presented in Figure <ref type="figure" target="#fig_4">2A</ref>.</s><s>Delta LVEF was slightly higher in the 8W group (þ24 ± 11%) compared with the 1W group (þ21 ± 11%) but this was not statistically significant (P = 0.381) with 2.5 [95% confidence limit: -3.2; 8.3]%.</s></p><p><s>In order to analyse effects of the two treatment concepts in more critically ill patients, a subgroup analysis was performed including only patients in whom baseline LVEF was &lt;30%.</s><s>As shown in Figure <ref type="figure" target="#fig_4">2B</ref>, the LVEF increased from a mean of 21 ± 6% at baseline to 45 ± 14% at 6 months in the 1W group (n = 14), and from 21 ± 6% to 50 ± 11% in the 8W group (n = 18) again showing a slightly higher delta LVEF in the 8W subgroup (þ29 ± 10%) as compared with delta LVEF of the 1W subgroup (þ24 ± 11%) which was not statistically significant (8W vs. 1W: P = 0.222).</s><s>Between-groups differences at 6-months follow-up of LVEF change of 4.3 [95% confidence limit: -4.6; 13.2]% and for LVEF change of 4.7 [95% confidence limit: -2.9; 12.4]% in favour of the 8W groups were observed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Recovery rate of left ventricular function in peripartum cardiomyopathy patients after 6-months follow-up</head><p><s>After 6 months follow-up 52% of the 1W-patients (n = 32) showed full functional LV recovery (LVEF &gt; _50%), 21% partial recovery (LVEF between 35% and &lt;50%) and 28% no recovery (LVEF &lt;35%), prematurely terminated the trial or had missing LVEF data.</s><s>In the 8W arm (n = 31), the respective rates were 68% for full functional recovery, 25% for partial recovery, and 7% for no recovery.</s><s>Full recovery rates showed a descriptive benefit for the 8W group (68% compared with 52% in 1W group).</s><s>Fisher exact test (two-sided) resulted in P = 0.283 and revealed an OR= 0.508 [confidence limit: 0.173, 1.490] showing that-although not significant-the risk within the 8W group to fail 'full recovery' after 6 months is reduced.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Change in left ventricular function over time as assessed by echocardiography</head><p><s>We also analysed LVEF determined by echocardiography, which was performed immediately after patients' inclusion (Visit 1) with sequential performance at 2 weeks (Visit 2), 1 month (Visit 3), 3 months (Visit 4) and 6 months (Visit 5) after randomization (Figure <ref type="figure" target="#fig_3">3B</ref>).</s><s>Echocardiographic recordings meeting the quality standards of the core lab were available from 45 patients displaying a mean baseline LVEF of 23 ± 7%.</s><s>There was no difference in baseline LVEF measured by echocardiography between the 1W (23 ± 7%, n = 21) and the 8W (23 ± 8%, n = 24) group.</s><s>After the 6 months follow-up, the absolute improvement (delta LVEF) in the 1W group was þ25 ± 12% and þ27 ± 11% in the 8W group, which was not statistically significant (P = 0.581).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Secondary end points of study outcome</head><p><s>Secondary end points were hospitalization for heart failure, cardiac transplantation, and death of patient during trial, or combinations of these conditions (Table <ref type="table">2</ref>).</s><s>Among the patients of the 1W group 3 of 31 (=9.7%) and among the patients of the 8W group 2 of 31 (=6.5%) were hospitalized for heart failure until the end of study (Table <ref type="table">2</ref>).</s><s>Only one patient was listed for transplantation during the trial but was removed from the waiting list at follow-up due to improvement of the clinical condition and cardiac function.</s><s>None of the patients received a left ventricular assist device (LVAD) or a heart transplantation, and no patient died.</s><s>Altogether, the secondary end points of clinical events did not significantly differ between treatment groups (P = 0.651).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Safety of study treatment</head><p><s>A total of six serious adverse events (SAEs) in four patients were reported, and all SAEs occurred in patients of the 1W group (Table <ref type="table" target="#tab_2">3</ref>).</s><s>Therefore, no dose relationship can be concluded from the results.</s><s>For three of the SAEs, causality was considered possible with respect to treatment with bromocriptine.</s><s>In all three cases, SAE occurred after termination of bromocriptine therapy.</s><s>These SAEs included two venous embolisms and one peripheral artery occlusion.</s><s>A complete list of all adverse events (AEs) and adverse reactions is provided in the Supplementary material online, Appendix Tables S12-S14.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Comparison of outcome with IPAC study</head><p><s>As a limitation of our study, we do not have a placebo control group because it was considered unethical given the results of previous registry data and pilot studies <ref type="bibr" target="#b12">12,</ref><ref type="bibr" target="#b16">16,</ref><ref type="bibr" target="#b17">17</ref> and the risk for mastitis for stopping lactation without medical support.</s><s>We therefore compared a subgroup of our collective characterized by a baseline LVEF &lt;30% (echocardiography) with a subgroup of PPCM patients with a baseline LVEF &lt;30% (echocardiography) from the Investigation in Pregnancy Associate Cardiomyopathy (IPAC) collective, which has been analysed over the same time period and obtaining comparable standard therapy for heart failure but no bromocriptine. <ref type="bibr" target="#b19">19</ref></s><s>In the IPAC subgroup (n = 27 patients), 37% remained in severe heart failure after a follow-up period of 6-12 months.</s><s>In addition, the rate of transplantation and/or use of LVAD was 19%, and the mortality rate was 15% (Table <ref type="table" target="#tab_1">4</ref>).</s><s>In the present study, 37 patients (n = 18 in the 1W and n = 19 in the 8W group) displayed a baseline LVEF &lt;30% with at least 6-months follow-up.</s><s>No patient in the 1W or the 8W group died, needed heart transplantation or a LVAD (Table <ref type="table" target="#tab_1">4</ref>).</s><s>In the 1W group two and in the 8W group three patients did not recover LVEF above 35% after 6 months.</s><s>Follow-up analyses after &gt; _12 months were available for these five patients showing that three patients displayed complete recovery (LVEF &gt; _50%), and one patient showed substantial recovery with an LVEF of 47% and only one patient in the 8W group remained in severe heart failure (Table <ref type="table" target="#tab_1">4</ref>).</s><s>However, this patient showed poor adherence to standard heart failure medication during follow-up.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Our study is the first prospective, randomized, and multicentre trial at adequate size to test short-vs.</s><s>long-term inhibition of prolactin by bromocriptine as a causal therapy for PPCM.</s><s>It demonstrates that inhibition of prolactin release with long-term or short-term bromocriptine in addition to standard therapy for heart failure in patients with severe forms of PPCM is associated with a high recovery rate and very low rate of adverse outcome.</s><s>1]<ref type="bibr" target="#b22">[22]</ref><ref type="bibr" target="#b23">[23]</ref><ref type="bibr" target="#b24">[24]</ref><ref type="bibr" target="#b25">[25]</ref><ref type="bibr" target="#b26">[26]</ref> In addition, our study population tolerated bromocriptine well suggesting that both, short-and long-term application appear to be safe since attention was paid to ensure sufficient anticoagulant therapy during treatment.</s><s>The study did not detect a significant benefit for prolonged inhibition of prolactin release with bromocriptine in addition to standard therapy for heart failure in increasing LVEF or reducing hospitalization for heart failure compared with short-term bromocriptine application sufficient to stop lactation in patients with PPCM.</s><s>However, we observed a trend for more patients reaching full recovery after 6 months in the 8W group suggesting a small benefit of prolonged bromocriptine treatment.</s></p><p><s><ref type="bibr" target="#b10">[10]</ref> The nursing hormone prolactin and specifically its cleaved 16 kDa form is considered to play a key role in the pathophysiology of PPCM (Figure <ref type="figure" target="#fig_5">4</ref>). <ref type="bibr" target="#b12">12,</ref><ref type="bibr" target="#b13">13,</ref><ref type="bibr" target="#b16">16,</ref><ref type="bibr" target="#b17">17</ref></s><s>However, unlike the placebo controlled study by Sliwa et al. <ref type="bibr" target="#b17">17</ref> the present study was not designed to compare bromocriptine therapy with placebo but to compare two different dose regimes of bromocriptine in severely diseased PPCM patients: A short-term regime that is sufficient to suppress lactation and a longterm regime that may exert additional cardioprotective effects.</s></p><p><s>The primary end point of our study, the global improvement in LVEF at 6 months, was not significantly different among the shortterm and long-term bromocriptine groups, although the long-term treatment descriptively showed a higher rate of predefined full LV recovery.</s><s>It is important to note, that the overall outcome among all patients enrolled in this study was better than the outcome of any prospective study on PPCM reported so far: Only 7% of all patients remaining in the study with complete data sets were still in severe LV dysfunction (EF &lt;35%) at 6-months follow-up and only 3% remained One patient of the 1W group who was not treated according to the protocol but received higher dose of bromocriptine (up to 10 mg) for a relevantly longer time was excluded from the endpoint analysis.</s><s>in heart failure thereafter.</s><s>Moreover, none of the patients experienced a major adverse event including death, cardiac transplantation or LVAD implantation.</s><s>It has to be noted that all patients were randomized no longer than 7 days after first diagnosis in a severe disease state (LVEF &lt; _35%), thereby no selection for more stable patients was ensured.</s><s>In a comparable group of patients in Germany, we previously reported a 15% treatment failure in a German registry with prospective data of 96 PPCM patients despite standard heart failure drug therapy. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b16">16</ref></s><s>Importantly, in the German registry the percentage of patients with persistent severe LV dysfunction was significantly higher among those patients who did not receive bromocriptine.</s><s>The rate of maternal major adverse events among all patients in the German registry was 10% with a mortality rate of 2%.</s><s>Interestingly, in the recent prospective North American IPAC study including PPCM patients with LVEF &lt; 45% a comparable event rate of 7% and a mortality rate of about 4% were reported. <ref type="bibr" target="#b19">19</ref></s><s>In the IPAC study a subgroup of severely diseased patients with an LVEF &lt;30% was analysed of whom 37% reached an LVEF &gt; _50% (full recovery) and an equal number, 37% experienced a major event (transplantation/LVAD: 19% or death: 15%) or a final LVEF &lt;35%. <ref type="bibr" target="#b19">19</ref></s><s>We identified a similar subgroup in our study that presented with a baseline LVEF &lt;30%, that however displayed a substantially better outcome (62% full recovery and 0% LVAD, HTX or death, only 3% with persistently LVEF &lt;35%).</s><s>Although this indirect comparison has to be interpreted with caution given some differences in the population characteristics, in particular the proportion of patients with African origin (2% in our study vs. 27% in the IPAC study) for whom prognosis might be worse, <ref type="bibr" target="#b21">21</ref> it seems to further support the view that there is a benefit of bromocriptine treatment.</s><s>In fact, also in non-African countries, i.e. for example in Turkey, mortality rates for PPCM between 25 and 30% were reported. <ref type="bibr" target="#b20">20</ref></s><s>In view of these studies, a treatment concept that combines short-term low dose bromocriptine with standard heart failure therapy, as evaluated in the present study, appears to be associated with a better outcome, although a number of factors have to be taken into account which may have an impact on patient outcome, such as different ethnicities with potentially different genetic dispositions and different medical care opportunities.</s></p><p><s>An important reason for the beneficial effect of bromocriptine treatment may also be the associated ablactation which enables early  The one patient of the 1W group who was not treated according to the protocol but received higher dose of bromocriptine (up to 10 mg) for a relevantly longer time was included in the safety analyses.</s><s>optimal heart failure treatment with beta-blockade, ACE inhibition, MRA, and ivabradine. <ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b27">27</ref></s><s>No controlled studies have ever analysed the potential adverse effects of heart failure medication transferred to the infant in the breast milk, whereas normal growth percentiles and no adverse outcome were observed for the infants of PPCM patients in South Africa who terminated breastfeeding. <ref type="bibr" target="#b17">17</ref></s><s>Thus, terminating breastfeeding with bromocriptine appears to be safe for the child and may enable implementation of early intensive heart failure therapy at high dosages associated with faster recovery of the mother enabling her to better care for her newborn.</s><s>Some concerns have been raised about a potential risk for cerebral and cardiovascular complications in patients treated with high doses of bromocriptine. <ref type="bibr" target="#b28">28,</ref><ref type="bibr" target="#b29">29</ref></s><s>However, our observation that no adverse event associated with bromocriptine occurred during bromocriptine treatment in both groups suggests that bromocriptine (together with anticoagulant therapy) is safe and potentially effective in PPCM patients although the optimal dosage and duration of therapy to achieve maximal cardioprotective effects still remains a matter of investigation.</s><s>Future studies should also explore whether extended prophylactic anticoagulation beyond the period of bromocriptine treatment is required in these patients with a considerable risk of thromboembolism.</s></p><p><s>Recent nation-wide observations and population-based studies estimated a rise in incidence of PPCM worldwide, <ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref> emphasizing that future research should focus on investigating preventive strategies.</s><s>Moreover, modern echocardiography and cardiac magnetic resonance imaging have broadened the phenotypic profile of PPCM showing for example, that in about one-third of PPCM patients the right ventricle is affected by the disease with lower likelihood to recover despite optimal therapy. <ref type="bibr" target="#b30">30</ref></s><s>The phenotypic heterogeneity of this disease with variable outcome may reflect additional contributing factors such as genetic or (auto-)immune mechanisms <ref type="bibr" target="#b31">31,</ref><ref type="bibr" target="#b32">32</ref> that may determine the course of disease and the clinical outcome.</s><s>Thus, the challenge of future research will be to elaborate specific therapeutic concepts for patients who are likely to be refractory to current treatment options.</s><s>Since improvement of LV function was similar between the two bromocriptine regiments, an outcome study testing the concept appears worthwhile.</s><s>Currently, our own experience suggests that critically ill patients (baseline LVEF &lt;25%, cardiogenic chock) may profit from a prolonged treatment with a higher initial dosage of bromocriptine (see Supplementary material online, Figure <ref type="figure" target="#fig_0">S1</ref>), a feature that is also supported by the trend for faster fullrecovery in the 8W group.</s><s>This hypothesis needs to be scrutinized in a prospective randomized outcome trial.</s></p><p><s>In conclusion, the findings of our study further support a potential benefit of bromocriptine in addition to standard heart failure therapy and best supportive care in PPCM patients (Figure <ref type="figure" target="#fig_5">4</ref>).</s><s>It appears that a short low dose bromocriptine therapy aiming to stop lactation is sufficient in most forms of PPCM.</s><s>However, the limited numbers of patients available in single countries warrant large international prospective registries, i.e.</s><s>PPCM EORP registry [ESC EURObservational Research Programme (http://www.eorp.org)], to get further insights into the efficiency of treatment strategies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Manufacturer of the study drug</head><p><s>AbZ-Pharma GmbH</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1</head><label>1</label><figDesc><div><p><s>Figure1Randomization, treatment, and follow-up of the patients.</s><s>Left ventricular ejection fraction (LVEF), §patient was excluded from all between-groups comparisons for efficacy; *23 with adequate imaging quality for primary end point.</s><s># 28 with adequate imaging quality for primary end point.</s><s>§One patient was not treated according to protocol and excluded from efficacy analyses.</s></p></div></figDesc><graphic coords="2,324.62,428.66,205.55,193.83" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>4. IQR, interquartile range; NYHA, New York Heart Association.</s><s>a Race or ethnic group was reported by the investigators.</s><s>b The body mass index is the weight in kilograms divided by the square of the height in meters.</s><s>c The data for right ventricular ejection fraction were available for n = 44 patients (1W: n = 20; 8W: n = 24).</s><s>d The data for NYHA class reflect the status of patients at the time of randomization. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2</head><label>2</label><figDesc><div><p><s>Figure 2 Analyses of global left ventricular ejection fraction (LVEF) change from baseline to 6 months follow-up determined by CMR.</s><s>(A) Individual courses of LVEF change from baseline to 6months follow-up in the 1W group (n = 23) and 8W group (n = 28) with a between-groups difference at 6-months follow-up of 2.0% in favour of the 8W groups (P = 0.38).</s><s>(B) Individual courses of LVEF change from baseline to 6-months follow-up for the subgroup of patients with LVEF &lt;30% at study entry in the 1 W group (n = 14) and the 8W group (n = 18) with between-groups differences at 6months follow-up of 4.3% and for LVEF change of 4.7% in favour of the 8W groups (P = 0.22).</s></p></div></figDesc><graphic coords="4,326.04,75.80,203.59,175.86" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3</head><label>3</label><figDesc><div><p><s>Figure 3 Outcome of patients at 6-months follow-up.</s><s>(A) Left ventricular ejection fraction (LVEF) at 6-months follow-up according to predefined categories in all patients of the present study (treated 1W, n = 32 or 8W, n = 31 with bromocriptine, baseline LVEF &lt;35%).</s><s>Red columns illustrate the percentage of patients with no recovery (event or final LVEF &lt;35%, prematurely terminated the trial or had missing LVEF data), yellow columns illustrate the percentage of patients with partial recovery (final LVEF 35% to &lt; 50%) and green columns depict percentage of women with complete recovery (final LVEF &gt; _50%).</s><s>(B) Step-wise change in LVEF measured by echocardiography during follow-up period in the 1 W (n = 21) and the 8W group (n = 24).</s><s>The number 1-5 marks time course of the five patients who did not recover LVEF &gt;35% after 6-months.</s><s>However, after &gt; _12 months Number 1 displayed a LVEF = 62%, 2 a LVEF = 47%, 3 and 4 a LVEF = 50%, and 5 a LVEF = 15%.</s></p></div></figDesc><graphic coords="5,132.04,75.80,336.41,245.76" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Table 2</head><label>2</label><figDesc><div><p><s>.................................................................................................................................................................................................................... Effect of treatment on secondary end points End point 1W bromocriptine (N 5 31) a 8W bromocriptine (N 5 31)</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 4</head><label>4</label><figDesc><div><p><s>Figure 4 Disease specific therapy with bromocritine.</s><s>Scheme depicting inducers of increased oxidative stress in the peripartum maternal heart that mediate the generation of antiangiogenic 16kDa prolactin from the nursing hormone prolactin which drives PPCM as well as the hypothetic mechanisms how the prolactin release blocker bromocriptine together with standard heart failure medication interferes with it.</s></p></div></figDesc><graphic coords="6,138.16,75.80,315.30,248.15" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head></head><label></label><figDesc><div><p><s>....................................................................................................................................................................................................................</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>b</head><label></label><figDesc><div><p><s>Occlusion was due to air embolism as a complication during coronary angiography. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>).</s><s>No patient in the 1W group resumed lactation after bromocriptine treatment.</s><s>.................................................................................................................................................................................................................... Baseline characteristics of all randomized patients</s></p></div></figDesc><table><row><cell>Characteristic</cell><cell>1W bromocriptine (N 5 32)</cell><cell>8W bromocriptine (N 5 31)</cell></row><row><cell>Age-year</cell><cell>33.8 ± 5.8</cell><cell>34.0 ± 4.5</cell></row><row><cell>Median gravida (range)</cell><cell>1.5 (1-7)</cell><cell>2 (1-5)</cell></row><row><cell>Median parity (range)</cell><cell>1.5 (1-7)</cell><cell>2 (1-6)</cell></row><row><cell>Race or ethnic group-number (%) a</cell><cell></cell><cell></cell></row><row><cell>Caucasian</cell><cell>32 (100)</cell><cell>30 (97)</cell></row><row><cell>Black</cell><cell>0 (0)</cell><cell>1 (3)</cell></row><row><cell>Systolic blood pressure-mmHg</cell><cell>117 ± 18</cell><cell>111 ± 17</cell></row><row><cell>Heart rate-beats per minute</cell><cell>90 ± 16</cell><cell>84 ± 12</cell></row><row><cell>Body mass index b</cell><cell>28.3 ± 6.8</cell><cell>29.0 ± 7.9</cell></row><row><cell>Serum creatinine-mg/dL</cell><cell>0.8 ± 0.2</cell><cell>0.9 ± 0.2</cell></row><row><cell>Clinical features of heart failure</cell><cell></cell><cell></cell></row><row><cell>Left ventricular ejection fraction-(%)</cell><cell>28 ± 10</cell><cell>27 ± 9</cell></row><row><cell>Right ventricular ejection fraction-(%) c</cell><cell>48 ± 12</cell><cell>42 ± 13</cell></row><row><cell>Median NT-proBNP-pg/mL</cell><cell>2164 (1290-3066)</cell><cell>2437 (1423-4158)</cell></row><row><cell>NYHA functional class-number (%) d</cell><cell></cell><cell></cell></row><row><cell>I</cell><cell>0 (0)</cell><cell>1 (3.2)</cell></row><row><cell>II</cell><cell>4 (12.5)</cell><cell>4 (12.9)</cell></row><row><cell>III</cell><cell>10 (31.3)</cell><cell>9 (29.0)</cell></row><row><cell>IV</cell><cell>18 (56.3)</cell><cell>17 (54.8)</cell></row><row><cell>Medical history-number (%)</cell><cell></cell><cell></cell></row><row><cell>Hypertension</cell><cell>7 (21.9)</cell><cell>11 (35.5)</cell></row><row><cell>Diabetes</cell><cell>2 (6.3)</cell><cell>1 (3.2)</cell></row><row><cell>Smoker or former smoker</cell><cell>16 (50)</cell><cell>15 (48)</cell></row><row><cell>Pregnancy related conditions-number (%)</cell><cell></cell><cell></cell></row><row><cell>Preeclampsia</cell><cell>5 (15,6)</cell><cell>8 (25.8)</cell></row><row><cell>Gestational diabetes</cell><cell>3 (9.4)</cell><cell>2 (6.5)</cell></row><row><cell>Treatment at randomization-number (%)</cell><cell></cell><cell></cell></row><row><cell>ACE inhibitor</cell><cell>30 (93.8)</cell><cell>27 (87.1)</cell></row><row><cell>Angiotensin receptor blocker</cell><cell>3 (9.4)</cell><cell>3 (9.7)</cell></row><row><cell>Mineralcorticoid antagonist</cell><cell>27 (84.6)</cell><cell>25 (80.6)</cell></row><row><cell>Beta-blocker</cell><cell>29 (90.6)</cell><cell>31 (100)</cell></row><row><cell>Diuretic</cell><cell>28 (88.5)</cell><cell>28 (90.3)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 4</head><label>4</label><figDesc><div><p><s>19fect of treatment on outcome in peripartum cardiomyopathy patients with left ventricular ejection fraction &lt;30% in the bromocriptine study (treated either with 1W or 8W bromocriptine) compared with the IPAC study without bromocriptine treatment19LVEF was analysed by echocardiography in the core labs of both studies.Follow-up in the IPAC study was 12 months, follow-up in our study was at 6-36 months.LVEF, left ventricular ejection fraction; LVAD, left ventricular assist device; HTX, heart transplantation.....................................................................................................................................................................................................................</s></p></div></figDesc><table><row><cell>Follow-up</cell><cell>1W bromocriptine</cell><cell>8W bromocriptine</cell><cell>1W and 8W bromocriptine</cell><cell>IPAC study placebo</cell></row><row><cell>characteristics</cell><cell>baseline LVEF</cell><cell>baseline</cell><cell>baseline LVEF</cell><cell>baseline LVEF</cell></row><row><cell></cell><cell>&lt;30% (n 5 18)</cell><cell>LVEF &lt;30% (n 5 19)</cell><cell>&lt;30% (n 5 37)</cell><cell>&lt;30% (n 5 27)</cell></row><row><cell>LVEF &lt;35%</cell><cell>0% (0/18)</cell><cell>5% (1/19)</cell><cell>3% (1/37)</cell><cell>37%</cell></row><row><cell>LVEF 35-49%</cell><cell>22% (6/18)</cell><cell>37% (7/19)</cell><cell>35% (13/37)</cell><cell>26%</cell></row><row><cell>Full recovery, LVEF &gt; _50</cell><cell>67% (12/18)</cell><cell>58% (11/19)</cell><cell>62% (23/37)</cell><cell>37%</cell></row><row><cell>LVAD and HTX</cell><cell>0% (0/18)</cell><cell>0% (0/19)</cell><cell>0% (0/37)</cell><cell>19% (5/27)</cell></row><row><cell>Death</cell><cell>0% (0/18)</cell><cell>0% (0/19)</cell><cell>0% (0/37)</cell><cell>15% (4/27)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc><div><p><s>Incidence of serious adverse events during the study by system organ class</s></p></div></figDesc><table><row><cell>System organ class</cell><cell>1W bromocriptine (N 5 32) a</cell><cell>Relation to bromocriptine</cell><cell>8W bromocriptine (N 5 31)</cell><cell>P-value</cell></row><row><cell>Cardiac disorders</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Coronary artery occlusion b 1 (3.2)</cell><cell>Not related</cell><cell>0(0)</cell><cell>1.000</cell></row><row><cell>Musculoskeletal disorders</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Chest pain</cell><cell>1 (3.2)</cell><cell>Unlikely related</cell><cell>0(0)</cell><cell>1.000</cell></row><row><cell>Respiratory disorders</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Dyspnoea</cell><cell>1 (3.2)</cell><cell>Unlikely related</cell><cell>0(0)</cell><cell>1.000</cell></row><row><cell>Vascular disorders</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Venous Embolism</cell><cell>2 (6.4)</cell><cell>Possibly related</cell><cell>0(0)</cell><cell>0.491</cell></row><row><cell>Peripheral artery occlusion</cell><cell>1 (3.2)</cell><cell>Possibly related</cell><cell>0(0)</cell><cell>1.000</cell></row><row><cell>Data are numbers of events (%).</cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>a</s></p></note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We thank S. Gutzke, B. Ritter, S. Tammen, M. Kasten, and M. Jungesblut for technical assistance.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supplementary material</head><p><s>Supplementary material is available at European Heart Journal online.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">K</forename><surname>Sliwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Elkayam</surname></persName>
		</author>
		<author>
			<persName><surname>Peripartum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">368</biblScope>
			<biblScope unit="page" from="687" to="693" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Peripartum cardiomyopathy: current management and future perspectives</title>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Haghikia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nonhoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bauersachs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1090" to="1097" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Pathophysiology and epidemiology of peripartum cardiomyopathy</title>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sliwa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cardiol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="364" to="370" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sliwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Petrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mebazaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pieske</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Buchmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Regitz-Zagrosek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schaufelberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tavazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Van Veldhuisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Watkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Seferovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Elkayam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pankuweit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Papp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mouquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Mcmurray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Heart Fail</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="767" to="778" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Incidence, mortality, and racial differences in peripartum cardiomyopathy</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Brar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Sandhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Jorgensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Parikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Shen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="302" to="304" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide populationbased study</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kolte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Khera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Aronow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Palaniswamy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mujib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Panza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Fonarow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Heart Assoc</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e001056</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Incidence and prevalence of pregnancy associated heart disease</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sliwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Boehm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Res</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="554" to="560" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy</title>
		<author>
			<persName><forename type="first">J</forename><surname>Bauersachs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Arrigo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Veltmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Coats</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Crespo-Leiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Boer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Van Der Meer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Maack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mouquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Petrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Piepoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Regitz-Zagrosek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Schaufelberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Seferovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tavazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ruschitzka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mebazaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sliwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Heart Fail</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1096" to="1105" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">P</forename><surname>Ponikowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Voors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Anker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bueno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Cleland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Coats</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Falk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Gonzalez-Juanatey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Harjola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Jankowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jessup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Linde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nihoyannopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Parissis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pieske</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Riley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Rosano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Ruilope</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ruschitzka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Rutten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Van Der Meer</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Authors/Task Force</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Document</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Heart Fail</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="891" to="975" />
			<date type="published" when="2016">2016. 2016</date>
		</imprint>
	</monogr>
	<note>Developed with the special contribution of the Heart Failure Association (HFA) of the ESC</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">V</forename><surname>Regitz-Zagrosek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Blomstrom</forename><surname>Lundqvist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Borghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cifkova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Foidart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gibbs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Gohlke-Baerwolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gorenek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Iung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kirby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Morais</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nihoyannopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pieper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Presbitero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Roos-Hesselink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Schaufelberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Seeland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Torracca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bax</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Auricchio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baumgartner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ceconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Deaton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fagard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Funck-Brentano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hasdai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hoes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Knuuti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kolh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mcdonagh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Moulin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Poldermans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Popescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Reiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sechtem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Sirnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Torbicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vahanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Windecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Aguiar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Al-Attar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Antoniou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Coman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Elkayam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Gomez-Sanchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Gotcheva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Kitsiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Konings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Lip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">Y</forename><surname>Manolis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mebaaza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mintale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Morice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Mulder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Pasquet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Priori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Salvador</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Shotan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Silversides</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Skouby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">O</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Tornos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Vejlstrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Warnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="3147" to="3197" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy</title>
		<author>
			<persName><forename type="first">J</forename><surname>Halkein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Tabruyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ricke-Hoch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Haghikia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">Q</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scherr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Castermans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Malvaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Thiry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sliwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Noel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Martial</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Struman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="2143" to="2154" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy</title>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kaminski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Podewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bonda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schaefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sliwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Forster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Quint</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Landmesser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Doerries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Luchtefeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Poli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Balligand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Desjardins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ansari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Struman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">Q</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Zschemisch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Heusch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hilfiker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Drexler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="589" to="600" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Cardiac angiogenic imbalance leads to peripartum cardiomyopathy</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Patten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shahul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Rowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Hacker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Rhee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mahmood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Farrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Koulisis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Khankin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Burke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Tudorache</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bauersachs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Del Monte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Karumanchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Arany</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">485</biblScope>
			<biblScope unit="page" from="333" to="338" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ricke-Hoch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Bultmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Stapel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Condorelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Rinas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sliwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scherr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Res</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="587" to="596" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Cardiovascular and renal effects of bromocriptine in diabetic patients with stage 4 chronic kidney disease</title>
		<author>
			<persName><forename type="first">O</forename><surname>Mejia-Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Herrera-Abarca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ceballos-Reyes</forename></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Avila-Diaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Prado-Uribe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Belio-Caro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Salinas-Gonzalez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vega-Gomez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Alvarez-Aguilar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Garcia-Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Paniagua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomed Res Int</title>
		<imprint>
			<biblScope unit="page">104059</biblScope>
			<date type="published" when="2013">2013. 2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Haghikia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Podewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Libhaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Labidi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Roentgen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tsikas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jordan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lichtinghagen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Von Kaisenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Struman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bovy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sliwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bauersachs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Basic Res Cardiol</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page">366</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sliwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Blauwet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tibazarwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Libhaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Smedema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcmurray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yamac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Labidi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Struman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="1465" to="1473" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Haghikia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Podewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Berliner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sonnenschein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Angermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bohm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rontgen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bauersachs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Res Cardiol</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="911" to="917" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Mcnamara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Elkayam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Alharethi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Damp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hsich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ewald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Modi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alexis</forename><forename type="middle">Jd</forename><surname>Ramani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V</forename><surname>Semigran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Haythe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Markham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Marek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Halder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Pisarcik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Fett JD; Investigators I. Clinical outcomes for peripartum cardiomyopathy in North America: results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy</title>
				<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="905" to="914" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Peripartum cardiomyopathy in Turkey</title>
		<author>
			<persName><forename type="first">M</forename><surname>Biteker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="e60" to="e61" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Predictors of outcome in 176 South African patients with peripartum cardiomyopathy</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Blauwet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Libhaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Forster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tibazarwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mebazaa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sliwa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="308" to="313" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Insights from Haiti regarding a disease of unknown etiology</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Fett</surname></persName>
		</author>
		<author>
			<persName><surname>Peripartum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Minn Med</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="46" to="48" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Fett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Christie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Carraway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Murphy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mayo Clin Proc</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="1602" to="1606" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. Results from the Japanese Nationwide survey of peripartum cardiomyopathy</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Kamiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kitakaze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ishibashi-Ueda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nakatani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Murohara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tomoike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ikeda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ J</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="1975" to="1981" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use</title>
		<author>
			<persName><forename type="first">J</forename><surname>Pillarisetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kondur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Alani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Reddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vacek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Weiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ellerbeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Schreiber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lakkireddy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">25</biblScope>
			<biblScope unit="page" from="2831" to="2839" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>Pt A</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Long-term outcome of peripartum cardiomyopathy in a population with high seropositivity for human immunodeficiency virus</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sliwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Forster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tibazarwa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Libhaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="page" from="202" to="208" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Early ivabradine treatment in patients with acute peripartum cardiomyopathy: subanalysis of the German PPCM registry</title>
		<author>
			<persName><forename type="first">A</forename><surname>Haghikia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tongers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Berliner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Konig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schafer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bohm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bauersachs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">216</biblScope>
			<biblScope unit="page" from="165" to="167" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Myocardial infarction postpartum in patients taking bromocriptine for the prevention of breast engorgement</title>
		<author>
			<persName><forename type="first">L</forename><surname>Hopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Haider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Iffy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="227" to="232" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Severe cardiac dysrhythmia in patients using bromocriptine postpartum</title>
		<author>
			<persName><forename type="first">L</forename><surname>Iffy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Correia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Ther</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="111" to="115" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Haghikia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rontgen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vogel-Claussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schwab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Westenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ehlermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Berliner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Podewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bauersachs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ESC Heart Fail</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="139" to="149" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Evidence of autoantibodies against cardiac troponin I and sarcomeric myosin in peripartum cardiomyopathy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Haghikia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Kaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schwab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Westenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ehlermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bachelier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Oettl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Von Kaisenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Katus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bauersachs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Basic Res Cardiol</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page">60</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Shared genetic predisposition in peripartum and dilated cardiomyopathies</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Ware</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mazaika</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Yasso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Desouza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Cappola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilfiker-Kleiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Kamiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mazzarotto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Halder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pisarcik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hanley-Yanez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Alharethi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Damp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hsich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Elkayam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sheppard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kealey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alexis</forename><forename type="middle">J</forename><surname>Ramani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Safirstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Boehmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pauly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Wittstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Thohan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Zucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mcnamara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Seidman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Seidman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Arany Z; Imac, Investigators I</title>
				<imprint>
			<date type="published" when="2016">2016</date>
			<biblScope unit="volume">374</biblScope>
			<biblScope unit="page" from="233" to="241" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
